There have been a slew of studies recently supporting the notion that the same mechanisms that help folks lose weight ...

New research finds that semaglutide medications like Ozempic and Wegovy may help to lower the risk of alcohol-related issues.

Some GLP-1 receptor agonists may hold promise as treatments for alcohol use disorder (AUD), a Swedish observational study ...

The primary exposure was the use of GLP-1 agonists, including exenatide, liraglutide, dulaglutide, and semaglutide (with ...

Examples include dulaglutide, exenatide extended-release, liraglutide and semaglutide (injectable and oral). Short-acting RA: ...

SAN ANTONIO -- Research presented at the ObesityWeek annual meeting included studies on rationing of prescription medications ...

Semaglutide offers a multifaceted approach to type 2 diabetes treatment, enhancing insulin release and reducing blood sugar ...

There’s been lots of attention on type 2 diabetes drugs recently, especially since they might also be able to support weight ...

A Novo Nordisk Phase 3 trial found that 37% of adults with metabolic dysfunction-associated steatohepatitis who received once-weekly semaglutide 2.4 milligrams showed improvement in liver fibrosis ...

Semaglutide, the weight management drug sold as Ozempic and Wegovy, may reduce the risk of Alzheimer's disease by 40% to 70% compared to similar medications, a new study found. But experts say more ...